IPP Bureau

T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy
T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy

By IPP Bureau - June 15, 2026

Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform

Ramkrishna CARE Hospitals’s dedicated cancer institute to open in August 2026
Ramkrishna CARE Hospitals’s dedicated cancer institute to open in August 2026

By IPP Bureau - June 15, 2026

The new institute will strengthen oncology infrastructure in central India with advanced radiation therapy, multidisciplinary expertise, and comprehensive cancer care services

Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push
Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push

By IPP Bureau - June 15, 2026

Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing

Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai
Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai

By IPP Bureau - June 15, 2026

The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments

Leprosy elimination drive intensifies as Indian govt pushes high-burden states toward zero transmission goal
Leprosy elimination drive intensifies as Indian govt pushes high-burden states toward zero transmission goal

By IPP Bureau - June 15, 2026

Patnaik stressed early diagnosis, rapid treatment, and aggressive surveillance as the backbone of elimination efforts

Cohere Health’s Global Innovation Centre recognized as impactful at ET Edge GCC Summit
Cohere Health’s Global Innovation Centre recognized as impactful at ET Edge GCC Summit

By IPP Bureau - June 15, 2026

Award highlights Hyderabad-based innovation hub’s role in advancing healthcare technology, clinical intelligence, and global operational excellence

Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO
Cohance Lifesciences shareholders back Umang Vohra as Chairman and Group CEO

By IPP Bureau - June 15, 2026

Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy

Redcliffe Labs expands Rajasthan footprint with strategic acquisition
Redcliffe Labs expands Rajasthan footprint with strategic acquisition

By IPP Bureau - June 15, 2026

Acquisition strengthens integrated radiology and pathology capabilities, enhancing access to advanced diagnostics and preventive healthcare

PULSUS targets 6,000 jobs at Rs. 500 crore Ameenpur AI Healthcare Hub
PULSUS targets 6,000 jobs at Rs. 500 crore Ameenpur AI Healthcare Hub

By IPP Bureau - June 15, 2026

Supreme Court grants PULSUS Ameenpur project ITeS Park and SEZ status, strengthening Telangana's position in AI, healthcare technology, and digital services

ZoBio launches DEL platform to accelerate drug discovery for challenging targets
ZoBio launches DEL platform to accelerate drug discovery for challenging targets

By IPP Bureau - June 15, 2026

New hit discovery service combines integrated DNA-Encoded Library screening, structural biology, biophysics, and X-ray crystallography

Medtronic launches PulseSelect PFA system in India
Medtronic launches PulseSelect PFA system in India

By IPP Bureau - June 15, 2026

New-generation cardiac ablation technology expands treatment options for atrial fibrillation patients, offering a non-thermal approach to improve safety and procedural efficiency

Maiva Pharma inaugurates advanced sterile injectables manufacturing facility in Tamil Nadu
Maiva Pharma inaugurates advanced sterile injectables manufacturing facility in Tamil Nadu

By IPP Bureau - June 15, 2026

New Shoolagiri plant strengthens Maiva’s global CDMO capabilities with advanced isolator technology, flexible production lines, and expanded capacity for complex injectable therapies

Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers

By IPP Bureau - June 15, 2026

Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise

Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026
Suven Life Sciences to showcase narcolepsy program Samelisant at SLEEP 2026

By IPP Bureau - June 14, 2026

Samelisant will be the centerpiece of Suven’s scientific presence

Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio
Alembic secures USFDA nod for Tretinoin Cream strengthening generics portfolio

By IPP Bureau - June 14, 2026

The approval clears the company to market a generic version that is therapeutically equivalent to Retin-A Cream

Latest Stories

Interviews

Packaging